Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study
Lawitz, Eric, Landis, Charles S, Flamm, Steven L, Bonacini, Maurizio, Ortiz-Lasanta, Grisell, Huang, Jonathan, Zhang, Jie, Kirby, Brian J, De-Oertel, Shampa, Hyland, Robert H, Osinusi, Anu O, BrainardJournal:
The Lancet Gastroenterology & Hepatology
DOI:
10.1016/S2468-1253(19)30417-0
Date:
June, 2020
File:
PDF, 368 KB
2020